Prevalence of metabolic syndrome components in an urban Mexican sample: comparison between two classifications
- PMID: 22203834
- PMCID: PMC3235771
- DOI: 10.1155/2012/202540
Prevalence of metabolic syndrome components in an urban Mexican sample: comparison between two classifications
Abstract
Background. The aim of this study was to examine the prevalence of metabolic syndrome (MS) components in an urban Mexican sample. Methods. A total of 854 subjects were included. Anthropometric, blood pressure measurements, clinical data, and overnight fasting blood samples were obtained from all subjects. Results. In accordance with definitions by the American Heart Association/ National Heart, Lung, and Blood Institute (AHA/NHLBI) and the International Diabetes Federation (IDF), the prevalence of MS among participants was 59.7 and 68.7%, respectively. The prevalence of MS was higher in women and in individuals older than 45 years of age. More than 40% of the subjects fulfilled four criterions of MS according to both definitions. Conclusions. There was a high prevalence of MS components in an urban Mexican sample. Therefore, strong strategies had to be developed for early detection of MS and its components to prevent DMT2 and atherothrombotic complications in these patients.
Figures
References
-
- Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607. - PubMed
-
- Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine. 1998;15(7):539–553. - PubMed
-
- Cleeman JI. Executive summary of the third report of the national cholesterol education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) Journal of the American Medical Association. 2001;285(19):2486–2497. - PubMed
-
- Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—A new world-wide definition. A consensus statement from the international diabetes federation. Diabetic Medicine. 2006;23(5):469–480. - PubMed
-
- Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–1778. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical